Target intelligence / Profile preview

TEM-1 β-lactamase (TEM-1)

Target
TEM-1
Molecular classification
Enzyme, Hydrolase, Class A β-lactamase, Serine β-lactamase
01

Overview

TEM-1 β-lactamase is a class A serine hydrolase enzyme, most commonly found in Gram-negative bacteria, and responsible for resistance to penicillins and early generation cephalosporins. Engineered versions involve specific mutations, substitutions, or chimeric recombinations to probe enzymatic properties, substrate scope, stability, and inhibitor susceptibility. Its catalytic mechanism involves a nucleophilic serine attacking the β-lactam ring of antibiotics, facilitating hydrolysis and drug inactivation[1][2][3][4][5][6]. Engineered mutants are also critical for studying the molecular evolution and biophysical characterization of β-lactamase function, as well as developing new antibacterial strategies. The clinical significance of TEM-1 and its derivatives rests in their roles in multidrug-resistant infections, which continue to drive the need for novel therapies and diagnostic monitoring.

Other names
TEM β-lactamaseTEM-1 penicillinaseClass A β-lactamase (TEM-type)Engineered TEMLaboratory-engineered TEM-1 β-lactamase
02

Mechanism of action

Hydrolysis of the β-lactam ring of antibiotics, leading to inactivation of the antimicrobial agent and ensuing resistance[1][2][3][4][5]. Mutations and engineered alterations can extend substrate specificity or confer resistance to β-lactamase inhibitors[2][4][5].

03

Biological functions

Antibiotic resistanceHydrolysis of β-lactam antibioticsEnzymatic degradation of penicillins and cephalosporins
04

Disease associations

InfectionAntimicrobial resistanceNosocomial (hospital-acquired) infections
05

Safety considerations

Rapid emergence and dissemination of resistance genesLimitation of existing antibiotic efficacyNeed for close monitoring in clinical settings due to resistance developmentPotential for horizontal gene transfer leading to widespread resistance
06

Interacting drugs

Ampicillin

6 more in the full profile.

07

Biomarkers

Presence of TEM-1 β-lactamase gene in clinical isolates as a marker for β-lactam antibiotic resistance[4][5].Specific amino acid substitutions (e.g., G238S, E104K) for ESBL phenotype[2][4][5].

Beyond the preview

Go deeper on TEM-1 β-lactamase (TEM-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TEM-1 β-lactamase (TEM-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call